Patients with Clostridium Difficile-Associated Diarrhoea (Cdad)
Linked as:
Summary
M2 EQUITYBITES-May 30, 2011-Optimer's DIFICID tablets approved by FDA for the treatment of patients with Clostridium difficile- Associated Diarrhoea (CDAD)
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
Patients with Clostridium Difficile-Associated Diarrhoea (Cdad)
Biopharmaceutical company Optimer Pharmaceuticals Inc (Nasdaq:OPTR) on Friday announced that t...
See the full content of this document
Sponsored links
